Healthy volunteers test new drug combo in early safety trial
NCT ID NCT07181538
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This early-phase study tested two experimental drugs, JLP-2302 and JP-1366, in 55 healthy volunteers to see how the body processes them and if they are safe. Participants were adults with a normal body weight and no major health issues. The goal was to gather basic safety and drug-level information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.